Cisapride

Generic name: Pronounced as (sis' a pride)
Brand names
  • Propulsid®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 11/15/2017

Cisapride is only available in the United States to special patients who are signed up by their doctors. Talk to your doctor or pharmacist about whether you should be taking cisapride.

Cisapride may cause serious irregular heart beats, which can lead to death. Tell your doctor if you have a family history of heart problems and if you have or have ever had irregular heart beats, heart disease, severe dehydration, vomiting, eating disorders, or kidney or lung failure.

Tell your doctor about all the prescription and nonprescription medications you are taking. Do not take cisapride if you are taking bepridil (Vascor); chlorpromazine (Thorazine); clarithromycin (Biaxin); erythromycin (E.E.S., E-Mycin, Ery-Tab); fluconazole (Diflucan); fluphenazine (Prolixin); itraconazole (Sporanox); ketoconazole (Nizoral); medications for depression such as amitriptyline (Elavil), amoxapine (Asendin), clomipramine (Anafranil), desipramine (Norpramin), doxepin (Adapin, Sinequan), imipramine (Tofranil), maprotiline (Ludiomil), nefazodone (Serzone), nortriptyline (Pamelor), protriptyline (Vivactil), and trimipramine (Surmontil); medications for irregular heart beats such as amiodarone (Cordarone), disopyramide (Norpace), quinidine (Quinidex), procainamide (Procanbid, Pronestyl), and sotalol (Betapace); mesoridazine (Serentil); perphenazine (Trilafon); prochlorperazine (Compazine); promethazine (Phenergan); protease inhibitors such as indinavir (Crixivan) and ritonavir (Norvir); sertindole (Serlect); sparfloxacin (Zagam); thioridazine (Mellaril); thiothixene (Navane); trifluoperazine (Stelazine); or troleandomycin (Tao). Do not drink grapefruit juice while taking cisapride.

Do not take more of cisapride or take it more often than prescibed by your doctor. Keep all appointments with your doctor and the laboratory. Your doctor will order certain lab tests to check your body's response to cisapride.

If you experience either of the following symptoms, call your doctor immediately: fainting or irregular or fast heartbeats.

Cisapride is used to treat symptoms of nighttime heartburn in people who have not responded to other treatments.

Cisapride comes as a tablet and liquid to take by mouth. Cisapride usually is taken four times a day, 15 minutes before meals and at bedtime. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take cisapride exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

This medication should not be prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking cisapride,

  • tell your doctor and pharmacist if you are allergic to cisapride or any other drugs.

  • in addition to the medications listed in the IMPORTANT WARNING section, tell your doctor and pharmacist what prescription and nonprescription medications you are taking, especially antianxiety medications, anticholinergics (atropine, belladonna, benztropine, dicyclomine, diphenhydramine, isopropamide, procyclidine, and scopolamine), anticoagulants ('blood thinners') such as warfarin (Coumadin), azithromycin (Zithromax), cimetidine (Tagamet), dirithromycin (Dynabac), diuretics ('water pills'), miconazole (Monistat), tranquilizers, and vitamins.

  • tell your doctor if you have or have ever had intestinal disorders or bleeding ulcers.

  • tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking cisapride, call your doctor.

  • you should know that this drug may make you drowsy. Do not drive a car or operate machinery until you know how this drug affects you.

  • remember that alcohol can add to the drowsiness caused by this drug.

Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

  • Cisapride may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • diarrhea

    • upset stomach

    • stomach discomfort

    • headache

    • stuffy nose

    • constipation

    • coughing

  • If you experience any of the following symptoms or those listed in the IMPORTANT WARNING section call your doctor immediately:

    • vision changes

    • chest pain

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Keep all appointments with your doctor and the laboratory. Your doctor will order certain lab tests to check your response to cisapride.

Do not let anyone else take your medicine. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Moxifloxacin Moxifloxacin The risk or severity of QTc prolongation can be increased when Moxifloxacin is combined with Cisapride.
Repaglinide Repaglinide The metabolism of Repaglinide can be decreased when combined with Cisapride.
Montelukast Montelukast The metabolism of Cisapride can be decreased when combined with Montelukast.
Leflunomide Leflunomide The metabolism of Leflunomide can be decreased when combined with Cisapride.
Delavirdine Delavirdine The metabolism of Cisapride can be decreased when combined with Delavirdine.
Nevirapine Nevirapine The metabolism of Cisapride can be increased when combined with Nevirapine.
Atorvastatin Atorvastatin The metabolism of Atorvastatin can be decreased when combined with Cisapride.
Dolasetron Dolasetron The risk or severity of QTc prolongation can be increased when Dolasetron is combined with Cisapride.
Aminophylline Aminophylline The metabolism of Aminophylline can be decreased when combined with Cisapride.
Anagrelide Anagrelide The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Cisapride.
Candesartan Candesartan The metabolism of Cisapride can be decreased when combined with Candesartan.
Cilostazol Cilostazol The metabolism of Cilostazol can be decreased when combined with Cisapride.
Clopidogrel Clopidogrel The metabolism of Clopidogrel can be decreased when combined with Cisapride.
Diphenoxylate Diphenoxylate The risk or severity of adverse effects can be increased when Cisapride is combined with Diphenoxylate.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole The serum concentration of Cisapride can be increased when it is combined with Erythromycin.
Fenofibrate Fenofibrate The metabolism of Fenofibrate can be decreased when combined with Cisapride.
Guanfacine Guanfacine The risk or severity of adverse effects can be increased when Cisapride is combined with Guanfacine.
Methylergonovine Methylergonovine The metabolism of Cisapride can be decreased when combined with Methylergometrine.
Naratriptan Naratriptan The risk or severity of adverse effects can be increased when Cisapride is combined with Naratriptan.
Paregoric Paregoric The metabolism of Cisapride can be decreased when combined with Morphine.
Penbutolol Penbutolol The metabolism of Acebutolol can be decreased when combined with Cisapride.
Pentazocine Pentazocine The risk or severity of adverse effects can be increased when Cisapride is combined with Pentazocine.
Prednisone Prednisone The metabolism of Cisapride can be increased when combined with Prednisone.
Reserpine Reserpine The metabolism of Cisapride can be increased when combined with Reserpine.
Rizatriptan Rizatriptan The risk or severity of adverse effects can be increased when Cisapride is combined with Rizatriptan.
Sumatriptan Sumatriptan The risk or severity of adverse effects can be increased when Cisapride is combined with Sumatriptan.
Tacrolimus Tacrolimus The metabolism of Tacrolimus can be decreased when combined with Cisapride.
Tizanidine Tizanidine The risk or severity of QTc prolongation can be increased when Tizanidine is combined with Cisapride.
Triamcinolone Triamcinolone The metabolism of Cisapride can be increased when combined with Triamcinolone.
Zolmitriptan Zolmitriptan The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Cisapride.
Doxycycline Injection Doxycycline Injection The metabolism of Cisapride can be decreased when combined with Doxycycline.
Famotidine Injection Famotidine Injection The risk or severity of QTc prolongation can be increased when Famotidine is combined with Cisapride.
Fluconazole Injection Fluconazole Injection The metabolism of Cisapride can be decreased when combined with Fluconazole.
Foscarnet Injection Foscarnet Injection The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Cisapride.
Hydromorphone Injection Hydromorphone Injection The risk or severity of adverse effects can be increased when Hydromorphone is combined with Cisapride.
Levofloxacin Injection Levofloxacin Injection The risk or severity of QTc prolongation can be increased when Levofloxacin is combined with Cisapride.
Meperidine Injection Meperidine Injection The metabolism of Meperidine can be decreased when combined with Cisapride.
Methylprednisolone Injection Methylprednisolone Injection The metabolism of Cisapride can be increased when combined with Methylprednisolone.
Metoclopramide Injection Metoclopramide Injection The risk or severity of sedation can be increased when Metoclopramide is combined with Cisapride.
Metronidazole Injection Metronidazole Injection The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Cisapride.
Morphine Injection Morphine Injection The metabolism of Cisapride can be decreased when combined with Morphine.
Zidovudine Injection Zidovudine Injection The metabolism of Zidovudine can be decreased when combined with Cisapride.
Altretamine Altretamine The metabolism of Amphetamine can be decreased when combined with Cisapride.
Cyclosporine Cyclosporine The metabolism of Cisapride can be decreased when combined with Cyclosporine.
Ondansetron Ondansetron The risk or severity of QTc prolongation can be increased when Cisapride is combined with Ondansetron.
Granisetron Granisetron The risk or severity of QTc prolongation can be increased when Granisetron is combined with Cisapride.
Torsemide Torsemide The metabolism of Cisapride can be decreased when combined with Torasemide.
Olanzapine Olanzapine The metabolism of Olanzapine can be decreased when combined with Cisapride.
Alosetron Alosetron The metabolism of Alosetron can be decreased when combined with Cisapride.
Dofetilide Dofetilide The risk or severity of QTc prolongation can be increased when Dofetilide is combined with Cisapride.
Entacapone Entacapone The risk or severity of adverse effects can be increased when Entacapone is combined with Cisapride.
Hydroxychloroquine Hydroxychloroquine The metabolism of Cisapride can be decreased when combined with Hydroxychloroquine.
Meloxicam Meloxicam The metabolism of Meloxicam can be decreased when combined with Cisapride.
Orlistat Orlistat The metabolism of Cisapride can be increased when combined with Orlistat.
Oxcarbazepine Oxcarbazepine The risk or severity of adverse effects can be increased when Cisapride is combined with Oxcarbazepine.
Zaleplon Zaleplon The risk or severity of adverse effects can be increased when Cisapride is combined with Zaleplon.
Anakinra Anakinra The metabolism of Cisapride can be increased when combined with Anakinra.
Desloratadine Desloratadine The risk or severity of QTc prolongation can be increased when Desloratadine is combined with Cisapride.
Linezolid Linezolid The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Cisapride.
Trimipramine Trimipramine The metabolism of Trimipramine can be decreased when combined with Cisapride.
Etanercept Injection Etanercept Injection The metabolism of Cisapride can be increased when combined with Etanercept.
Glycopyrrolate Glycopyrrolate Cisapride may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.
Modafinil Modafinil The metabolism of Cisapride can be increased when combined with Modafinil.
Tenofovir Tenofovir The metabolism of Tenofovir can be decreased when combined with Cisapride.
Sirolimus Sirolimus The serum concentration of Cisapride can be increased when it is combined with Sirolimus.
Dutasteride Dutasteride The metabolism of Dutasteride can be decreased when combined with Cisapride.
Epinephrine Injection Epinephrine Injection The metabolism of Cisapride can be decreased when combined with Epinephrine.
Eplerenone Eplerenone The metabolism of Eplerenone can be decreased when combined with Cisapride.
Escitalopram Escitalopram The risk or severity of serotonin syndrome can be increased when Escitalopram is combined with Cisapride.
Zonisamide Zonisamide The risk or severity of QTc prolongation can be increased when Cisapride is combined with Zonisamide.
Adalimumab Injection Adalimumab Injection The metabolism of Cisapride can be increased when combined with Adalimumab.
Aripiprazole Aripiprazole The metabolism of Cisapride can be decreased when combined with Aripiprazole.
Atomoxetine Atomoxetine The metabolism of Atomoxetine can be decreased when combined with Cisapride.
Dexmethylphenidate Dexmethylphenidate The risk or severity of adverse effects can be increased when Cisapride is combined with Dexmethylphenidate.
Atazanavir Atazanavir The serum concentration of Cisapride can be increased when it is combined with Atazanavir.
Almotriptan Almotriptan The metabolism of Almotriptan can be decreased when combined with Cisapride.
Eletriptan Eletriptan The metabolism of Cisapride can be decreased when combined with Eletriptan.
Mefloquine Mefloquine The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Cisapride.
Rosuvastatin Rosuvastatin The metabolism of Rosuvastatin can be decreased when combined with Cisapride.
Vardenafil Vardenafil The risk or severity of QTc prolongation can be increased when Cisapride is combined with Vardenafil.
Alfuzosin Alfuzosin The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Cisapride.
Aprepitant Aprepitant The metabolism of Cisapride can be decreased when combined with Aprepitant.
Memantine Memantine The metabolism of Cisapride can be decreased when combined with Memantine.
Tegaserod Tegaserod The metabolism of Tegaserod can be decreased when combined with Cisapride.
Tadalafil Tadalafil The metabolism of Tadalafil can be decreased when combined with Cisapride.
Fosamprenavir Fosamprenavir The serum concentration of Cisapride can be increased when it is combined with Fosamprenavir.
Frovatriptan Frovatriptan The risk or severity of adverse effects can be increased when Cisapride is combined with Frovatriptan.
Gemifloxacin Gemifloxacin The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Cisapride.
Progesterone Progesterone The metabolism of Progesterone can be decreased when combined with Cisapride.
Apomorphine Injection Apomorphine Injection The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Cisapride.
Infliximab Injection Infliximab Injection The metabolism of Cisapride can be increased when combined with Infliximab.
Protriptyline Protriptyline The metabolism of Cisapride can be decreased when combined with Protriptyline.
Rifaximin Rifaximin The metabolism of Cisapride can be increased when combined with Rifaximin.
Duloxetine Duloxetine The metabolism of Duloxetine can be decreased when combined with Cisapride.
Norethindrone Norethindrone The metabolism of Norethisterone can be decreased when combined with Cisapride.
Trospium Trospium Cisapride may increase the central nervous system depressant (CNS depressant) activities of Trospium.
Bosentan Bosentan The metabolism of Cisapride can be increased when combined with Bosentan.
Erlotinib Erlotinib The metabolism of Erlotinib can be decreased when combined with Cisapride.
Eszopiclone Eszopiclone The risk or severity of CNS depression can be increased when Cisapride is combined with Eszopiclone.
Solifenacin Solifenacin The metabolism of Cisapride can be decreased when combined with Solifenacin.
Voriconazole Voriconazole The metabolism of Cisapride can be decreased when combined with Voriconazole.
Dextroamphetamine Dextroamphetamine The metabolism of Amphetamine can be decreased when combined with Cisapride.
Sodium Oxybate Sodium Oxybate Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Cisapride.
Ibandronate Ibandronate The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Cisapride.
Isocarboxazid Isocarboxazid The risk or severity of adverse effects can be increased when Cisapride is combined with Isocarboxazid.
Ramelteon Ramelteon The metabolism of Ramelteon can be decreased when combined with Cisapride.
Darifenacin Darifenacin The metabolism of Cisapride can be decreased when combined with Darifenacin.
Fentanyl Fentanyl The risk or severity of adverse effects can be increased when Cisapride is combined with Fentanyl.
Pregabalin Pregabalin The therapeutic efficacy of Cisapride can be increased when used in combination with Pregabalin.
Deferasirox Deferasirox The metabolism of Cisapride can be increased when combined with Deferasirox.
Tipranavir Tipranavir The serum concentration of Cisapride can be increased when it is combined with Tipranavir.
Felbamate Felbamate The risk or severity of QTc prolongation can be increased when Felbamate is combined with Cisapride.
Ranolazine Ranolazine The risk or severity of QTc prolongation can be increased when Ranolazine is combined with Cisapride.
Abatacept Injection Abatacept Injection The metabolism of Cisapride can be increased when combined with Abatacept.
Rasagiline Rasagiline The risk or severity of adverse effects can be increased when Cisapride is combined with Rasagiline.
Imatinib Imatinib The metabolism of Imatinib can be decreased when combined with Cisapride.
Sitagliptin Sitagliptin The metabolism of Sitagliptin can be decreased when combined with Cisapride.
Gefitinib Gefitinib The metabolism of Gefitinib can be decreased when combined with Cisapride.
Albuterol Albuterol The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Cisapride.
Paliperidone Paliperidone The risk or severity of QTc prolongation can be increased when Cisapride is combined with Paliperidone.
Bortezomib Bortezomib The metabolism of Bortezomib can be decreased when combined with Cisapride.
Oxaliplatin Injection Oxaliplatin Injection The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Cisapride.
Posaconazole Posaconazole The metabolism of Cisapride can be decreased when combined with Posaconazole.
Primaquine Primaquine The risk or severity of QTc prolongation can be increased when Primaquine is combined with Cisapride.
Darunavir Darunavir The serum concentration of Cisapride can be increased when it is combined with Darunavir.
Dimenhydrinate Dimenhydrinate The risk or severity of QTc prolongation can be increased when Dimenhydrinate is combined with Cisapride.
Lisdexamfetamine Lisdexamfetamine The metabolism of Lisdexamfetamine can be decreased when combined with Cisapride.
Nabilone Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Cisapride.
Vorinostat Vorinostat The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Cisapride.
Sorafenib Sorafenib The metabolism of Sorafenib can be decreased when combined with Cisapride.
Sunitinib Sunitinib The metabolism of Sunitinib can be decreased when combined with Cisapride.
Dronabinol Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Cisapride.
Lapatinib Lapatinib The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Cisapride.
Levocetirizine Levocetirizine The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Cisapride.
Dasatinib Dasatinib The metabolism of Dasatinib can be decreased when combined with Cisapride.
Mexiletine Mexiletine The metabolism of Cisapride can be decreased when combined with Mexiletine.
Armodafinil Armodafinil The metabolism of Cisapride can be increased when combined with Armodafinil.
Ivermectin Ivermectin The metabolism of Cisapride can be increased when combined with Ivermectin.
Temsirolimus Temsirolimus The serum concentration of Cisapride can be increased when it is combined with Temsirolimus.
Nilotinib Nilotinib The metabolism of Nilotinib can be decreased when combined with Cisapride.
Toremifene Toremifene The risk or severity of QTc prolongation can be increased when Toremifene is combined with Cisapride.
Bexarotene Bexarotene The metabolism of Cisapride can be increased when combined with Bexarotene.
Budesonide Budesonide The metabolism of Cisapride can be increased when combined with Budesonide.
Chloramphenicol Injection Chloramphenicol Injection The metabolism of Cisapride can be decreased when combined with Chloramphenicol.
OnabotulinumtoxinA Injection OnabotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Cisapride.
RimabotulinumtoxinB Injection RimabotulinumtoxinB Injection The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cisapride.
Etravirine Etravirine The metabolism of Cisapride can be increased when combined with Etravirine.
Arsenic Trioxide Injection Arsenic Trioxide Injection The risk or severity of QTc prolongation can be increased when Cisapride is combined with Arsenic trioxide.
Mitoxantrone Injection Mitoxantrone Injection The metabolism of Cisapride can be decreased when combined with Mitoxantrone.
Desvenlafaxine Desvenlafaxine The risk or severity of adverse effects can be increased when Cisapride is combined with Desvenlafaxine.
Cevimeline Cevimeline The metabolism of Cevimeline can be decreased when combined with Cisapride.
Nebivolol Nebivolol The metabolism of Nebivolol can be decreased when combined with Cisapride.
Tretinoin Tretinoin The metabolism of Tretinoin can be decreased when combined with Cisapride.
Pilocarpine Pilocarpine The metabolism of Cisapride can be decreased when combined with Pilocarpine.
Flecainide Flecainide The metabolism of Flecainide can be decreased when combined with Cisapride.
Certolizumab Injection Certolizumab Injection The metabolism of Cisapride can be increased when combined with Certolizumab pegol.
Ixabepilone Injection Ixabepilone Injection The serum concentration of Cisapride can be increased when it is combined with Ixabepilone.
Irinotecan Injection Irinotecan Injection The metabolism of Irinotecan can be decreased when combined with Cisapride.
Praziquantel Praziquantel The metabolism of Praziquantel can be decreased when combined with Cisapride.
Mitotane Mitotane The metabolism of Cisapride can be increased when combined with Mitotane.
Rufinamide Rufinamide The risk or severity of adverse effects can be increased when Rufinamide is combined with Cisapride.
Midazolam Midazolam The risk or severity of adverse effects can be increased when Cisapride is combined with Midazolam.
Naltrexone Injection Naltrexone Injection The risk or severity of serotonin syndrome can be increased when Cisapride is combined with Naltrexone.
Eltrombopag Eltrombopag The metabolism of Cisapride can be decreased when combined with Eltrombopag.
Milnacipran Milnacipran The risk or severity of adverse effects can be increased when Cisapride is combined with Milnacipran.
Fesoterodine Fesoterodine The metabolism of Fesoterodine can be decreased when combined with Cisapride.
Degarelix Injection Degarelix Injection The risk or severity of QTc prolongation can be increased when Degarelix is combined with Cisapride.
Betaxolol Betaxolol The metabolism of Betaxolol can be decreased when combined with Cisapride.
Iloperidone Iloperidone The metabolism of Iloperidone can be decreased when combined with Cisapride.
Prasugrel Prasugrel The metabolism of Prasugrel can be decreased when combined with Cisapride.
Lacosamide Lacosamide The risk or severity of adverse effects can be increased when Cisapride is combined with Lacosamide.
Everolimus Everolimus The serum concentration of Cisapride can be increased when it is combined with Everolimus.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) The metabolism of Tolvaptan can be decreased when combined with Cisapride.
Dronedarone Dronedarone Cisapride may increase the QTc-prolonging activities of Dronedarone.
AbobotulinumtoxinA Injection AbobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Cisapride.
Palonosetron Injection Palonosetron Injection The metabolism of Cisapride can be decreased when combined with Palonosetron.
Saxagliptin Saxagliptin The metabolism of Saxagliptin can be decreased when combined with Cisapride.
Telavancin Injection Telavancin Injection The risk or severity of QTc prolongation can be increased when Telavancin is combined with Cisapride.
Romidepsin Injection Romidepsin Injection The risk or severity of QTc prolongation can be increased when Cisapride is combined with Romidepsin.
Tapentadol Tapentadol Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Cisapride.
Topotecan Topotecan The metabolism of Cisapride can be increased when combined with Topotecan.
Golimumab Injection Golimumab Injection The metabolism of Cisapride can be increased when combined with Golimumab.
Pazopanib Pazopanib The metabolism of Pazopanib can be decreased when combined with Cisapride.
Asenapine Asenapine The risk or severity of QTc prolongation can be increased when Cisapride is combined with Asenapine.
Vigabatrin Vigabatrin The risk or severity of adverse effects can be increased when Cisapride is combined with Vigabatrin.
Pitavastatin Pitavastatin The metabolism of Pitavastatin can be decreased when combined with Cisapride.
Albendazole Albendazole The metabolism of Cisapride can be decreased when combined with Albendazole.
Levonorgestrel Levonorgestrel The metabolism of Cisapride can be decreased when combined with Levonorgestrel.
Oxymorphone Oxymorphone The metabolism of Oxymorphone can be decreased when combined with Cisapride.
Tocilizumab Injection Tocilizumab Injection The metabolism of Cisapride can be increased when combined with Tocilizumab.
Eribulin Injection Eribulin Injection The risk or severity of QTc prolongation can be increased when Eribulin is combined with Cisapride.
IncobotulinumtoxinA Injection IncobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Cisapride.
Cabazitaxel Injection Cabazitaxel Injection The metabolism of Cabazitaxel can be decreased when combined with Cisapride.
Lurasidone Lurasidone The risk or severity of adverse effects can be increased when Cisapride is combined with Lurasidone.
Acetaminophen Injection Acetaminophen Injection The metabolism of Acetaminophen can be decreased when combined with Cisapride.
Vilazodone Vilazodone The metabolism of Vilazodone can be decreased when combined with Cisapride.
Denileukin Diftitox Injection Denileukin Diftitox Injection The metabolism of Cisapride can be decreased when combined with Aldesleukin.
Terbutaline Injection Terbutaline Injection The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Cisapride.
Busulfan Injection Busulfan Injection The metabolism of Busulfan can be decreased when combined with Cisapride.
Roflumilast Roflumilast The metabolism of Roflumilast can be decreased when combined with Cisapride.
Linagliptin Linagliptin The metabolism of Cisapride can be decreased when combined with Linagliptin.
Rilpivirine Rilpivirine The metabolism of Cisapride can be decreased when combined with Rilpivirine.
Telaprevir Telaprevir The metabolism of Cisapride can be decreased when combined with Glecaprevir.
Cyclophosphamide Injection Cyclophosphamide Injection The metabolism of Cyclophosphamide can be decreased when combined with Cisapride.
Abiraterone Abiraterone The metabolism of Cisapride can be decreased when combined with Abiraterone.
Triptorelin Injection Triptorelin Injection The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Cisapride.
Rivaroxaban Rivaroxaban The metabolism of Rivaroxaban can be decreased when combined with Cisapride.
Ticagrelor Ticagrelor The metabolism of Cisapride can be decreased when combined with Ticagrelor.
Brentuximab Vedotin Injection Brentuximab Vedotin Injection The metabolism of Brentuximab vedotin can be decreased when combined with Cisapride.
Ruxolitinib Ruxolitinib The metabolism of Ruxolitinib can be decreased when combined with Cisapride.
Vandetanib Vandetanib The risk or severity of QTc prolongation can be increased when Cisapride is combined with Vandetanib.
Clobazam Clobazam The risk or severity of adverse effects can be increased when Clobazam is combined with Cisapride.
Vemurafenib Vemurafenib The risk or severity of QTc prolongation can be increased when Cisapride is combined with Vemurafenib.
Vismodegib Vismodegib The metabolism of Cisapride can be decreased when combined with Vismodegib.
Ivacaftor Ivacaftor The metabolism of Cisapride can be decreased when combined with Ivacaftor.
Axitinib Axitinib The metabolism of Axitinib can be decreased when combined with Cisapride.
Crizotinib Crizotinib The metabolism of Crizotinib can be decreased when combined with Cisapride.
Cabergoline Cabergoline The metabolism of Cabergoline can be decreased when combined with Cisapride.
Naloxone Injection Naloxone Injection The metabolism of Cisapride can be decreased when combined with Naloxone.
Ambrisentan Ambrisentan The metabolism of Ambrisentan can be decreased when combined with Cisapride.
Ezogabine Ezogabine The risk or severity of adverse effects can be increased when Cisapride is combined with Tiagabine.
Enzalutamide Enzalutamide The metabolism of Cisapride can be increased when combined with Enzalutamide.
Mirabegron Mirabegron The metabolism of Cisapride can be decreased when combined with Mirabegron.
Regorafenib Regorafenib The metabolism of Regorafenib can be decreased when combined with Cisapride.
Bosutinib Bosutinib The metabolism of Bosutinib can be decreased when combined with Cisapride.
Corticotropin, Repository Injection Corticotropin, Repository Injection The metabolism of Cisapride can be increased when combined with Corticotropin.
Teriflunomide Teriflunomide The metabolism of Cisapride can be decreased when combined with Teriflunomide.
Cabozantinib (thyroid cancer) Cabozantinib (thyroid cancer) The metabolism of Cabozantinib can be decreased when combined with Cisapride.
Bedaquiline Bedaquiline The risk or severity of QTc prolongation can be increased when Bedaquiline is combined with Cisapride.
Alogliptin Alogliptin The metabolism of Alogliptin can be decreased when combined with Cisapride.
Ponatinib Ponatinib The metabolism of Ponatinib can be decreased when combined with Cisapride.
Pomalidomide Pomalidomide The metabolism of Pomalidomide can be decreased when combined with Cisapride.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The metabolism of Trastuzumab emtansine can be decreased when combined with Cisapride.
Apixaban Apixaban The metabolism of Apixaban can be decreased when combined with Cisapride.
Dabrafenib Dabrafenib The metabolism of Dabrafenib can be decreased when combined with Cisapride.
Ospemifene Ospemifene The metabolism of Ospemifene can be decreased when combined with Cisapride.
Trametinib Trametinib The metabolism of Cisapride can be decreased when combined with Trametinib.
Levomilnacipran Levomilnacipran The metabolism of Cisapride can be decreased when combined with Levomilnacipran.
Vortioxetine Vortioxetine The metabolism of Vortioxetine can be decreased when combined with Cisapride.
Perampanel Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Cisapride.
Ibrutinib Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Cisapride.
Lomitapide Lomitapide The metabolism of Lomitapide can be decreased when combined with Cisapride.
Ketorolac Injection Ketorolac Injection The metabolism of Cisapride can be decreased when combined with Ketorolac.
Simeprevir Simeprevir The risk or severity of QTc prolongation and Cardiac Arrhythmia can be increased when Simeprevir is combined with Cisapride.
Dapagliflozin Dapagliflozin The metabolism of Dapagliflozin can be decreased when combined with Cisapride.
Apremilast Apremilast The metabolism of Apremilast can be increased when combined with Cisapride.
Ceritinib Ceritinib The risk or severity of QTc prolongation can be increased when Cisapride is combined with Ceritinib.
Siltuximab Injection Siltuximab Injection The metabolism of Cisapride can be increased when combined with Siltuximab.
Eslicarbazepine Eslicarbazepine The risk or severity of adverse effects can be increased when Cisapride is combined with Eslicarbazepine.
Idelalisib Idelalisib The metabolism of Idelalisib can be decreased when combined with Cisapride.
Testosterone Injection Testosterone Injection The metabolism of Cisapride can be increased when combined with Testosterone.
Oritavancin Injection Oritavancin Injection The metabolism of Cisapride can be increased when combined with Oritavancin.
Vorapaxar Vorapaxar The metabolism of Vorapaxar can be decreased when combined with Cisapride.
Hydrocodone Hydrocodone Hydrocodone may increase the central nervous system depressant (CNS depressant) activities of Cisapride.
Suvorexant Suvorexant Cisapride may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Olaparib Olaparib The metabolism of Olaparib can be decreased when combined with Cisapride.
Methamphetamine Methamphetamine The metabolism of Metamfetamine can be decreased when combined with Cisapride.
Tasimelteon Tasimelteon The risk or severity of adverse effects can be increased when Cisapride is combined with Tasimelteon.
Riociguat Riociguat The metabolism of Riociguat can be decreased when combined with Cisapride.
Lanreotide Injection Lanreotide Injection The metabolism of Cisapride can be decreased when combined with Lanreotide.
Nintedanib Nintedanib The metabolism of Nintedanib can be decreased when combined with Cisapride.
Secukinumab Injection Secukinumab Injection The metabolism of Cisapride can be increased when combined with Secukinumab.
Risperidone Injection Risperidone Injection The metabolism of Risperidone can be decreased when combined with Cisapride.
Palbociclib Palbociclib The metabolism of Palbociclib can be decreased when combined with Cisapride.
Lenvatinib Lenvatinib The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Cisapride.
Panobinostat Panobinostat The risk or severity of QTc prolongation can be increased when Panobinostat is combined with Cisapride.
Haloperidol Injection Haloperidol Injection The risk or severity of QTc prolongation can be increased when Haloperidol is combined with Cisapride.
Ivabradine Ivabradine The risk or severity of QTc prolongation can be increased when Cisapride is combined with Ivabradine.
Isavuconazonium Injection Isavuconazonium Injection The metabolism of Cisapride can be decreased when combined with Isavuconazonium.
Sonidegib Sonidegib The metabolism of Sonidegib can be decreased when combined with Cisapride.
Flibanserin Flibanserin The risk or severity of adverse effects can be increased when Cisapride is combined with Flibanserin.
Prednisolone Prednisolone The metabolism of Cisapride can be increased when combined with Prednisolone.
Daclatasvir Daclatasvir The metabolism of Daclatasvir can be decreased when combined with Cisapride.
Brexpiprazole Brexpiprazole The metabolism of Brexpiprazole can be decreased when combined with Cisapride.
Ziprasidone Injection Ziprasidone Injection The risk or severity of QTc prolongation can be increased when Ziprasidone is combined with Cisapride.
Cariprazine Cariprazine The metabolism of Cariprazine can be decreased when combined with Cisapride.
Eluxadoline Eluxadoline The risk or severity of serotonin syndrome can be increased when Cisapride is combined with Eluxadoline.
Cobimetinib Cobimetinib The metabolism of Cisapride can be decreased when combined with Cobimetinib.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Cisapride.
Osimertinib Osimertinib The metabolism of Osimertinib can be decreased when combined with Cisapride.
Alectinib Alectinib The metabolism of Alectinib can be decreased when combined with Cisapride.
Ixazomib Ixazomib The metabolism of Ixazomib can be decreased when combined with Cisapride.
Rifapentine Rifapentine The metabolism of Cisapride can be increased when combined with Rifapentine.
Lesinurad Lesinurad The metabolism of Cisapride can be increased when combined with Lesinurad.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection The metabolism of Cisapride can be decreased when combined with Amphotericin B.
Dexamethasone Injection Dexamethasone Injection The metabolism of Cisapride can be increased when combined with Dexamethasone.
Brivaracetam Injection Brivaracetam Injection The metabolism of Brivaracetam can be decreased when combined with Cisapride.
Venetoclax Venetoclax The metabolism of Venetoclax can be decreased when combined with Cisapride.
Cobicistat Cobicistat The risk or severity of QTc prolongation and Cardiac Arrhythmia can be increased when Cobicistat is combined with Cisapride.
Selexipag Selexipag The metabolism of Selexipag can be decreased when combined with Cisapride.
Pimavanserin Pimavanserin The risk or severity of adverse effects can be increased when Cisapride is combined with Pimavanserin.
Diphenhydramine Injection Diphenhydramine Injection The metabolism of Diphenhydramine can be decreased when combined with Cisapride.
Rucaparib Rucaparib The metabolism of Rucaparib can be decreased when combined with Cisapride.
Ribociclib Ribociclib The metabolism of Cisapride can be decreased when combined with Ribociclib.
Brigatinib Brigatinib The metabolism of Brigatinib can be decreased when combined with Cisapride.
Doxepin (Insomnia) Doxepin (Insomnia) The metabolism of Doxepin can be decreased when combined with Cisapride.
Deutetrabenazine Deutetrabenazine The serum concentration of the active metabolites of Deutetrabenazine can be increased when Deutetrabenazine is used in combination with Cisapride.
Valbenazine Valbenazine The metabolism of Valbenazine can be decreased when combined with Cisapride.
Deflazacort Deflazacort The metabolism of Cisapride can be increased when combined with Deflazacort.
Safinamide Safinamide The metabolism of Cisapride can be decreased when combined with Safinamide.
Sarilumab Injection Sarilumab Injection The metabolism of Cisapride can be increased when combined with Sarilumab.
Midostaurin Midostaurin The metabolism of Midostaurin can be increased when combined with Cisapride.
Neratinib Neratinib The metabolism of Neratinib can be decreased when combined with Cisapride.
Enasidenib Enasidenib The metabolism of Enasidenib can be decreased when combined with Cisapride.
Aprepitant/Fosaprepitant Injection Aprepitant/Fosaprepitant Injection The metabolism of Cisapride can be increased when combined with Fosaprepitant.
Copanlisib Injection Copanlisib Injection The metabolism of Copanlisib can be decreased when combined with Cisapride.
Delafloxacin Delafloxacin The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Cisapride.
Abemaciclib Abemaciclib The metabolism of Abemaciclib can be decreased when combined with Cisapride.
Acalabrutinib Acalabrutinib The metabolism of Acalabrutinib can be decreased when combined with Cisapride.
Letermovir Letermovir The metabolism of Letermovir can be decreased when combined with Cisapride.
Tetrabenazine Tetrabenazine The metabolism of Tetrabenazine can be decreased when combined with Cisapride.
Buprenorphine Injection Buprenorphine Injection Cisapride may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Apalutamide Apalutamide The metabolism of Cisapride can be increased when combined with Apalutamide.
Fostamatinib Fostamatinib The metabolism of Cisapride can be decreased when combined with Fostamatinib.
Avatrombopag Avatrombopag The metabolism of Cisapride can be increased when combined with Avatrombopag.
Baricitinib Baricitinib The metabolism of Baricitinib can be decreased when combined with Cisapride.
Lofexidine Lofexidine The therapeutic efficacy of Cisapride can be increased when used in combination with Lofexidine.
Eliglustat Eliglustat The metabolism of Eliglustat can be decreased when combined with Cisapride.
Encorafenib Encorafenib The metabolism of Encorafenib can be decreased when combined with Cisapride.
Ivosidenib Ivosidenib The risk or severity of QTc prolongation can be increased when Cisapride is combined with Ivosidenib.
Elagolix Elagolix The metabolism of Elagolix can be decreased when combined with Cisapride.
Doravirine Doravirine The metabolism of Doravirine can be decreased when combined with Cisapride.
Tafenoquine Tafenoquine The metabolism of Tafenoquine can be decreased when combined with Cisapride.
Cannabidiol Cannabidiol The risk or severity of adverse effects can be increased when Cannabidiol is combined with Cisapride.
Dacomitinib Dacomitinib The metabolism of Cisapride can be decreased when combined with Dacomitinib.
Duvelisib Duvelisib The metabolism of Duvelisib can be decreased when combined with Cisapride.
Stiripentol Stiripentol The metabolism of Cisapride can be decreased when combined with Stiripentol.
Gilteritinib Gilteritinib The therapeutic efficacy of Cisapride can be decreased when used in combination with Gilteritinib.
Glasdegib Glasdegib The risk or severity of QTc prolongation can be increased when Cisapride is combined with Glasdegib.
Lorlatinib Lorlatinib The metabolism of Lorlatinib can be decreased when combined with Cisapride.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be decreased when combined with Cisapride.
Rifamycin Rifamycin The metabolism of Cisapride can be increased when combined with Rifamycin.
Prucalopride Prucalopride The metabolism of Prucalopride can be decreased when combined with Cisapride.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The metabolism of Cisapride can be increased when combined with Emapalumab.
Siponimod Siponimod The metabolism of Siponimod can be decreased when combined with Cisapride.
Erdafitinib Erdafitinib The metabolism of Erdafitinib can be decreased when combined with Cisapride.
Alpelisib Alpelisib The metabolism of Alpelisib can be decreased when combined with Cisapride.
Brexanolone Injection Brexanolone Injection The risk or severity of adverse effects can be increased when Cisapride is combined with Brexanolone.
Solriamfetol Solriamfetol The risk or severity of adverse effects can be increased when Cisapride is combined with Solriamfetol.
Triclabendazole Triclabendazole The metabolism of Cisapride can be decreased when combined with Triclabendazole.
Entrectinib Entrectinib The risk or severity of QTc prolongation can be increased when Cisapride is combined with Entrectinib.
Pexidartinib Pexidartinib The metabolism of Pexidartinib can be decreased when combined with Cisapride.
Istradefylline Istradefylline The metabolism of Istradefylline can be decreased when combined with Cisapride.
Pitolisant Pitolisant The serum concentration of Pitolisant can be increased when it is combined with Cisapride.
Lefamulin Lefamulin Lefamulin may increase the QTc-prolonging activities of Cisapride.
Phenytoin Injection Phenytoin Injection The metabolism of Cisapride can be increased when combined with Phenytoin.
Fosphenytoin Injection Fosphenytoin Injection The metabolism of Cisapride can be increased when combined with Fosphenytoin.
Zanubrutinib Zanubrutinib The metabolism of Zanubrutinib can be decreased when combined with Cisapride.
Voxelotor Voxelotor The metabolism of Voxelotor can be decreased when combined with Cisapride.
Avapritinib Avapritinib The metabolism of Avapritinib can be decreased when combined with Cisapride.
Lumateperone Lumateperone The risk or severity of adverse effects can be increased when Cisapride is combined with Lumateperone.
Lasmiditan Lasmiditan The risk or severity of serotonin syndrome can be increased when Cisapride is combined with Lasmiditan.
Tazemetostat Tazemetostat The metabolism of Tazemetostat can be decreased when combined with Cisapride.
Cenobamate Cenobamate The serum concentration of Cisapride can be decreased when it is combined with Cenobamate.
Ozanimod Ozanimod The metabolism of Ozanimod can be decreased when combined with Cisapride.
Selumetinib Selumetinib The metabolism of Selumetinib can be decreased when combined with Cisapride.
Tucatinib Tucatinib The metabolism of Tucatinib can be decreased when combined with Cisapride.
Selpercatinib Selpercatinib The serum concentration of Cisapride can be increased when it is combined with Selpercatinib.
Lemborexant Lemborexant The serum concentration of Cisapride can be decreased when it is combined with Lemborexant.
Fenfluramine Fenfluramine The risk or severity of serotonin syndrome can be increased when Fenfluramine is combined with Cisapride.
Fostemsavir Fostemsavir The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Cisapride.
Octreotide Octreotide The risk or severity of QTc prolongation can be increased when Octreotide is combined with Cisapride.
Pralsetinib Pralsetinib The metabolism of Cisapride can be increased when combined with Pralsetinib.
Opicapone Opicapone The metabolism of Cisapride can be decreased when combined with Opicapone.
Satralizumab-mwge Injection Satralizumab-mwge Injection The serum concentration of Cisapride can be decreased when it is combined with Satralizumab.
Relugolix Relugolix The risk or severity of QTc prolongation can be increased when Relugolix is combined with Cisapride.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives The metabolism of Drospirenone can be decreased when combined with Cisapride.
Viloxazine Viloxazine The risk or severity of adverse effects can be increased when Cisapride is combined with Viloxazine.
Vitamin E (Alpha-Tocopherol) Vitamin E (Alpha-Tocopherol) The metabolism of Cisapride can be increased when combined with Vitamin E.
Theophylline Theophylline The metabolism of Cisapride can be decreased when combined with Theophylline.
Indomethacin Indomethacin The metabolism of Indomethacin can be decreased when combined with Cisapride.
Mefenamic Acid Mefenamic Acid The metabolism of Cisapride can be decreased when combined with Mefenamic acid.
Naproxen Naproxen The metabolism of Naproxen can be decreased when combined with Cisapride.
Trazodone Trazodone The risk or severity of QTc prolongation can be increased when Trazodone is combined with Cisapride.
Phenobarbital Phenobarbital The metabolism of Phenobarbital can be decreased when combined with Cisapride.
Metaxalone Metaxalone The risk or severity of adverse effects can be increased when Cisapride is combined with Metaxalone.
Methotrexate Injection Methotrexate Injection The metabolism of Methotrexate can be decreased when combined with Cisapride.
Levorphanol Levorphanol The risk or severity of adverse effects can be increased when Cisapride is combined with Levorphanol.
Primidone Primidone The metabolism of Cisapride can be increased when combined with Primidone.
Methsuximide Methsuximide The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Cisapride.
Diethylpropion Diethylpropion The risk or severity of adverse effects can be increased when Cisapride is combined with Diethylpropion.
Chlorpromazine Chlorpromazine The risk or severity of QTc prolongation can be increased when Cisapride is combined with Chlorpromazine.
Diazepam Diazepam The risk or severity of adverse effects can be increased when Cisapride is combined with Diazepam.
Oxazepam Oxazepam The risk or severity of adverse effects can be increased when Cisapride is combined with Oxazepam.
Flurazepam Flurazepam The metabolism of Flurazepam can be decreased when combined with Cisapride.
Clorazepate Clorazepate The risk or severity of adverse effects can be increased when Cisapride is combined with Clorazepic acid.
Lorazepam Lorazepam The risk or severity of adverse effects can be increased when Lorazepam is combined with Cisapride.
Amantadine Amantadine The risk or severity of QTc prolongation can be increased when Amantadine is combined with Cisapride.
Codeine Codeine The metabolism of Cisapride can be decreased when combined with Codeine.
Meprobamate Meprobamate The risk or severity of adverse effects can be increased when Meprobamate is combined with Cisapride.
Chlordiazepoxide Chlordiazepoxide The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Cisapride.
Bromocriptine Bromocriptine The risk or severity of adverse effects can be increased when Cisapride is combined with Bromocriptine.
Tranylcypromine Tranylcypromine The metabolism of Tranylcypromine can be decreased when combined with Cisapride.
Phenelzine Phenelzine The risk or severity of adverse effects can be increased when Cisapride is combined with Phenelzine.
Procarbazine Procarbazine The risk or severity of adverse effects can be increased when Cisapride is combined with Procarbazine.
Ergoloid Mesylates Ergoloid Mesylates The risk or severity of adverse effects can be increased when Cisapride is combined with Ergoloid mesylate.
Tetracycline Tetracycline The metabolism of Cisapride can be decreased when combined with Tetracycline.
Minocycline Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Cisapride.
Prochlorperazine Prochlorperazine The risk or severity of QTc prolongation can be increased when Prochlorperazine is combined with Cisapride.
Thioridazine Thioridazine The risk or severity of QTc prolongation can be increased when Cisapride is combined with Thioridazine.
Trifluoperazine Trifluoperazine The risk or severity of adverse effects can be increased when Cisapride is combined with Trifluoperazine.
Dapsone Dapsone The metabolism of Cisapride can be decreased when combined with Dapsone.
Sulfadiazine Sulfadiazine The metabolism of Cisapride can be decreased when combined with Sulfadiazine.
Oxycodone Oxycodone The metabolism of Cisapride can be decreased when combined with Oxycodone.
Methadone Methadone The risk or severity of adverse effects can be increased when Methadone is combined with Cisapride.
Oxybutynin Oxybutynin Cisapride may increase the central nervous system depressant (CNS depressant) activities of Oxybutynin.
Benztropine Benztropine The metabolism of Benzatropine can be decreased when combined with Cisapride.
Maprotiline Maprotiline The metabolism of Maprotiline can be decreased when combined with Cisapride.
Ibuprofen Ibuprofen The metabolism of Ibuprofen can be decreased when combined with Cisapride.
Trihexyphenidyl Trihexyphenidyl Cisapride may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl.
Orphenadrine Orphenadrine Cisapride may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Perphenazine Perphenazine The metabolism of Cisapride can be decreased when combined with Perphenazine.
Fluphenazine Fluphenazine The risk or severity of adverse effects can be increased when Cisapride is combined with Fluphenazine.
Phentermine Phentermine The metabolism of Cisapride can be decreased when combined with Phentermine.
Amoxapine Amoxapine The metabolism of Amoxapine can be decreased when combined with Cisapride.
Hydrocortisone Hydrocortisone The metabolism of Cisapride can be increased when combined with Hydrocortisone.
Doxorubicin Doxorubicin The metabolism of Doxorubicin can be decreased when combined with Cisapride.
Carbamazepine Carbamazepine The metabolism of Carbamazepine can be decreased when combined with Cisapride.
Molindone Molindone The risk or severity of adverse effects can be increased when Cisapride is combined with Molindone.
Clonidine Clonidine The risk or severity of sedation can be increased when Clonidine is combined with Cisapride.
Hydralazine Hydralazine The metabolism of Cisapride can be decreased when combined with Hydralazine.
Cimetidine Cimetidine The serum concentration of Cisapride can be increased when it is combined with Cimetidine.
Warfarin Warfarin The metabolism of Warfarin can be decreased when combined with Cisapride.
Clonazepam Clonazepam The risk or severity of adverse effects can be increased when Cisapride is combined with Clonazepam.
Loperamide Loperamide The risk or severity of QTc prolongation can be increased when Loperamide is combined with Cisapride.
Promethazine Promethazine The metabolism of Promethazine can be decreased when combined with Cisapride.
Daunorubicin Daunorubicin The metabolism of Cisapride can be decreased when combined with Daunorubicin.
Griseofulvin Griseofulvin The metabolism of Cisapride can be increased when combined with Griseofulvin.
Digoxin Digoxin The risk or severity of QTc prolongation can be increased when Digoxin is combined with Cisapride.
Loxapine Loxapine The risk or severity of adverse effects can be increased when Loxapine is combined with Cisapride.
Chloroquine Chloroquine The risk or severity of QTc prolongation can be increased when Cisapride is combined with Chloroquine.
Quinine Quinine The metabolism of Quinine can be decreased when combined with Cisapride.
Ethosuximide Ethosuximide The risk or severity of adverse effects can be increased when Ethosuximide is combined with Cisapride.
Calcitriol Calcitriol The metabolism of Cisapride can be increased when combined with Calcitriol.
Sulfinpyrazone Sulfinpyrazone The metabolism of Cisapride can be increased when combined with Sulfinpyrazone.
Clindamycin Injection Clindamycin Injection The serum concentration of Clindamycin can be increased when it is combined with Cisapride.
Secobarbital Secobarbital The metabolism of Cisapride can be increased when combined with Secobarbital.
Desipramine Desipramine The metabolism of Desipramine can be decreased when combined with Cisapride.
Amitriptyline Amitriptyline Amitriptyline may increase the arrhythmogenic activities of Cisapride.
Imipramine Imipramine The metabolism of Imipramine can be decreased when combined with Cisapride.
Probenecid Probenecid The metabolism of Cisapride can be increased when combined with Probenecid.
Quinidine Quinidine The metabolism of Quinidine can be decreased when combined with Cisapride.
Procainamide Procainamide The metabolism of Procainamide can be decreased when combined with Cisapride.
Isoniazid Isoniazid The metabolism of Cisapride can be decreased when combined with Isoniazid.
Rifampin Rifampin The metabolism of Cisapride can be increased when combined with Rifampicin.
Disopyramide Disopyramide The risk or severity of QTc prolongation can be increased when Disopyramide is combined with Cisapride.
Valproic Acid Valproic Acid The risk or severity of QTc prolongation can be increased when Valproic acid is combined with Cisapride.
Tamoxifen Tamoxifen The metabolism of Tamoxifen can be decreased when combined with Cisapride.
Butabarbital Butabarbital The risk or severity of adverse effects can be increased when Butabarbital is combined with Cisapride.
Levothyroxine Levothyroxine The metabolism of Cisapride can be decreased when combined with Levothyroxine.
Methimazole Methimazole The metabolism of Cisapride can be decreased when combined with Methimazole.
Chlorpropamide Chlorpropamide The metabolism of Chlorpropamide can be decreased when combined with Cisapride.
Tolbutamide Tolbutamide The metabolism of Tolbutamide can be decreased when combined with Cisapride.
Tolazamide Tolazamide The metabolism of Tolazamide can be decreased when combined with Cisapride.
Dextromethorphan Dextromethorphan The metabolism of Cisapride can be decreased when combined with Dextromethorphan.
Cyclobenzaprine Cyclobenzaprine The risk or severity of CNS depression can be increased when Cisapride is combined with Cyclobenzaprine.
Niacin Niacin The metabolism of Cisapride can be decreased when combined with Niacin.
Baclofen Baclofen The risk or severity of adverse effects can be increased when Baclofen is combined with Cisapride.
Doxylamine Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Cisapride.
Cyproheptadine Cyproheptadine The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Cisapride.
Clemastine Clemastine The risk or severity of QTc prolongation can be increased when Clemastine is combined with Cisapride.
Chlorpheniramine Chlorpheniramine The risk or severity of QTc prolongation can be increased when Cisapride is combined with Chlorpheniramine.
Brompheniramine Brompheniramine The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Cisapride.
Meclizine Meclizine The metabolism of Meclizine can be decreased when combined with Cisapride.
Hydrochlorothiazide Hydrochlorothiazide The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Cisapride.
Dantrolene Dantrolene The risk or severity of adverse effects can be increased when Cisapride is combined with Dantrolene.
Chlorzoxazone Chlorzoxazone The metabolism of Cisapride can be decreased when combined with Chlorzoxazone.
Carisoprodol Carisoprodol The risk or severity of adverse effects can be increased when Carisoprodol is combined with Cisapride.
Methocarbamol Methocarbamol The risk or severity of adverse effects can be increased when Methocarbamol is combined with Cisapride.
Danazol Danazol The metabolism of Cisapride can be decreased when combined with Danazol.
Disulfiram Disulfiram The risk or severity of QTc prolongation can be increased when Cisapride is combined with Disulfiram.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) The risk or severity of QTc prolongation can be increased when Propranolol is combined with Cisapride.
Pseudoephedrine Pseudoephedrine The risk or severity of serotonin syndrome can be increased when Cisapride is combined with Pseudoephedrine.
Nortriptyline Nortriptyline The metabolism of Nortriptyline can be decreased when combined with Cisapride.
Spironolactone Spironolactone The metabolism of Cisapride can be decreased when combined with Spironolactone.
Amphotericin B Injection Amphotericin B Injection The metabolism of Cisapride can be decreased when combined with Amphotericin B.
Nadolol Nadolol The metabolism of Nadolol can be decreased when combined with Cisapride.
Butorphanol Injection Butorphanol Injection The risk or severity of adverse effects can be increased when Cisapride is combined with Butorphanol.
Nalbuphine Injection Nalbuphine Injection The risk or severity of adverse effects can be increased when Cisapride is combined with Nalbuphine.
Oxytocin Injection Oxytocin Injection The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Cisapride.
Trimethobenzamide Trimethobenzamide The risk or severity of adverse effects can be increased when Cisapride is combined with Trimethobenzamide.
Flavoxate Flavoxate Cisapride may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.
Papaverine Papaverine The risk or severity of QTc prolongation can be increased when Papaverine is combined with Cisapride.
Fluorouracil Injection Fluorouracil Injection The metabolism of Cisapride can be decreased when combined with Fluorouracil.
Colchicine Colchicine The metabolism of Cisapride can be increased when combined with Colchicine.
Cephalexin Cephalexin The metabolism of Cisapride can be decreased when combined with Cephalexin.
Acetazolamide Acetazolamide The risk or severity of adverse effects can be increased when Cisapride is combined with Acetazolamide.
Ketoconazole Ketoconazole The metabolism of Cisapride can be decreased when combined with Ketoconazole.
Pyrantel Pyrantel The risk or severity of adverse effects can be increased when Cisapride is combined with Pyrantel.
Thiotepa Injection Thiotepa Injection The metabolism of Cisapride can be decreased when combined with Thiotepa.
Vincristine Injection Vincristine Injection The metabolism of Cisapride can be decreased when combined with Vincristine.
Vinblastine Vinblastine The metabolism of Vinblastine can be decreased when combined with Cisapride.
Metoprolol Metoprolol The metabolism of Cisapride can be decreased when combined with Metoprolol.
Hydroxyzine Hydroxyzine The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Cisapride.
Thiothixene Thiothixene The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Cisapride.
Aspirin Aspirin The metabolism of Acetylsalicylic acid can be decreased when combined with Cisapride.
Alprazolam Alprazolam The risk or severity of adverse effects can be increased when Alprazolam is combined with Cisapride.
Temazepam Temazepam The risk or severity of adverse effects can be increased when Temazepam is combined with Cisapride.
Triazolam Triazolam The risk or severity of adverse effects can be increased when Cisapride is combined with Triazolam.
Dicyclomine Dicyclomine Cisapride may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Hyoscyamine Hyoscyamine The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Cisapride.
Propantheline Propantheline Cisapride may increase the central nervous system depressant (CNS depressant) activities of Propantheline.
Trimethoprim Trimethoprim The metabolism of Trimethoprim can be decreased when combined with Cisapride.
Diltiazem Diltiazem The risk or severity of QTc prolongation can be increased when Diltiazem is combined with Cisapride.
Nifedipine Nifedipine The serum concentration of Nifedipine can be increased when it is combined with Cisapride.
Timolol Timolol The metabolism of Timolol can be decreased when combined with Cisapride.
Verapamil Verapamil The metabolism of Cisapride can be decreased when combined with Verapamil.
Atenolol Atenolol The metabolism of Atenolol can be decreased when combined with Cisapride.
Pindolol Pindolol The metabolism of Pindolol can be decreased when combined with Cisapride.
Cisplatin Injection Cisplatin Injection The metabolism of Cisapride can be decreased when combined with Cisplatin.
Piroxicam Piroxicam The metabolism of Cisapride can be decreased when combined with Piroxicam.
Etoposide Etoposide The metabolism of Etoposide can be decreased when combined with Cisapride.
Glyburide Glyburide The metabolism of Cisapride can be decreased when combined with Glyburide.
Glipizide Glipizide The metabolism of Glipizide can be decreased when combined with Cisapride.
Indapamide Indapamide The risk or severity of QTc prolongation can be increased when Indapamide is combined with Cisapride.
Dicloxacillin Dicloxacillin The metabolism of Cisapride can be increased when combined with Dicloxacillin.
Nafcillin Injection Nafcillin Injection The metabolism of Cisapride can be increased when combined with Nafcillin.
Pentamidine Injection Pentamidine Injection The metabolism of Pentamidine can be decreased when combined with Cisapride.
Labetalol Labetalol The metabolism of Labetalol can be decreased when combined with Cisapride.
Leuprolide Injection Leuprolide Injection The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Cisapride.
Gemfibrozil Gemfibrozil The metabolism of Cisapride can be decreased when combined with Gemfibrozil.
Ketoprofen Ketoprofen The metabolism of Cisapride can be decreased when combined with Ketoprofen.
Pimozide Pimozide The metabolism of Pimozide can be decreased when combined with Cisapride.
Flurbiprofen Flurbiprofen The metabolism of Flurbiprofen can be decreased when combined with Cisapride.
Amiodarone Amiodarone The metabolism of Amiodarone can be decreased when combined with Cisapride.
Buspirone Buspirone The metabolism of Cisapride can be decreased when combined with Buspirone.
Lovastatin Lovastatin The metabolism of Cisapride can be decreased when combined with Lovastatin.
Ciprofloxacin Ciprofloxacin The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Cisapride.
Diclofenac Diclofenac The metabolism of Diclofenac can be decreased when combined with Cisapride.
Fluoxetine Fluoxetine The risk or severity of serotonin syndrome can be increased when Fluoxetine is combined with Cisapride.
Nimodipine Nimodipine The risk or severity of QTc prolongation can be increased when Nimodipine is combined with Cisapride.
Clozapine Clozapine The risk or severity of QTc prolongation can be increased when Cisapride is combined with Clozapine.
Estazolam Estazolam The risk or severity of adverse effects can be increased when Cisapride is combined with Estazolam.
Idarubicin Idarubicin The metabolism of Idarubicin can be decreased when combined with Cisapride.
Ofloxacin Ofloxacin The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Cisapride.
Clarithromycin Clarithromycin The serum concentration of Cisapride can be increased when it is combined with Clarithromycin.
Etodolac Etodolac The metabolism of Etodolac can be decreased when combined with Cisapride.
Felodipine Felodipine The metabolism of Cisapride can be decreased when combined with Felodipine.
Nabumetone Nabumetone The metabolism of Nabumetone can be decreased when combined with Cisapride.
Simvastatin Simvastatin The metabolism of Simvastatin can be decreased when combined with Cisapride.
Teniposide Injection Teniposide Injection The metabolism of Teniposide can be decreased when combined with Cisapride.
Itraconazole Itraconazole The metabolism of Cisapride can be decreased when combined with Itraconazole.
Rifabutin Rifabutin The metabolism of Cisapride can be increased when combined with Rifabutin.
Sotalol Sotalol The metabolism of Sotalol can be decreased when combined with Cisapride.
Zolpidem Zolpidem Cisapride may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Doxazosin Doxazosin The metabolism of Cisapride can be decreased when combined with Doxazosin.
Isradipine Isradipine The metabolism of Cisapride can be decreased when combined with Isradipine.
Omeprazole Omeprazole The metabolism of Cisapride can be increased when combined with Omeprazole.
Gabapentin Gabapentin The risk or severity of adverse effects can be increased when Cisapride is combined with Gabapentin.
Fluvastatin Fluvastatin The metabolism of Fluvastatin can be decreased when combined with Cisapride.
Venlafaxine Venlafaxine The metabolism of Cisapride can be decreased when combined with Venlafaxine.
Famciclovir Famciclovir The metabolism of Cisapride can be decreased when combined with Famciclovir.
Fluvoxamine Fluvoxamine The metabolism of Fluvoxamine can be decreased when combined with Cisapride.
Nefazodone Nefazodone The metabolism of Nefazodone can be decreased when combined with Cisapride.
Lamotrigine Lamotrigine The risk or severity of QTc prolongation can be increased when Lamotrigine is combined with Cisapride.
Losartan Losartan The risk or severity of QTc prolongation can be increased when Losartan is combined with Cisapride.
Tramadol Tramadol The risk or severity of serotonin syndrome can be increased when Tramadol is combined with Cisapride.
Vinorelbine Injection Vinorelbine Injection The metabolism of Vinorelbine can be decreased when combined with Cisapride.
Moexipril Moexipril The risk or severity of QTc prolongation can be increased when Moexipril is combined with Cisapride.
Lansoprazole Lansoprazole The metabolism of Cisapride can be increased when combined with Lansoprazole.
Ifosfamide Injection Ifosfamide Injection The metabolism of Ifosfamide can be decreased when combined with Cisapride.
Nicardipine Nicardipine Cisapride may increase the central nervous system depressant (CNS depressant) activities of Nicardipine.
Bupropion Bupropion The risk or severity of adverse effects can be increased when Cisapride is combined with Bupropion.
Ticlopidine Ticlopidine The metabolism of Cisapride can be decreased when combined with Ticlopidine.
Saquinavir Saquinavir The serum concentration of Cisapride can be increased when it is combined with Saquinavir.
Nisoldipine Nisoldipine The metabolism of Cisapride can be decreased when combined with Nisoldipine.
Riluzole Riluzole The risk or severity of adverse effects can be increased when Cisapride is combined with Riluzole.
Glimepiride Glimepiride The metabolism of Glimepiride can be decreased when combined with Cisapride.
Anastrozole Anastrozole The metabolism of Anastrozole can be decreased when combined with Cisapride.
Indinavir Indinavir The serum concentration of Cisapride can be increased when it is combined with Indinavir.
Ritonavir Ritonavir The serum concentration of Cisapride can be increased when it is combined with Ritonavir.
Docetaxel Injection Docetaxel Injection The metabolism of Docetaxel can be decreased when combined with Cisapride.
Clomipramine Clomipramine The metabolism of Clomipramine can be decreased when combined with Cisapride.
Zafirlukast Zafirlukast The metabolism of Cisapride can be decreased when combined with Zafirlukast.
Mirtazapine Mirtazapine Cisapride may increase the serotonergic activities of Mirtazapine.
Topiramate Topiramate The risk or severity of adverse effects can be increased when Topiramate is combined with Cisapride.
Zileuton Zileuton The metabolism of Zileuton can be decreased when combined with Cisapride.
Valsartan Valsartan The metabolism of Valsartan can be decreased when combined with Cisapride.
Pramipexole Pramipexole Cisapride may increase the sedative activities of Pramipexole.
Donepezil Donepezil The metabolism of Donepezil can be decreased when combined with Cisapride.
Nelfinavir Nelfinavir The serum concentration of Cisapride can be increased when it is combined with Nelfinavir.
Azithromycin Azithromycin The serum concentration of Cisapride can be increased when it is combined with Azithromycin.
Loratadine Loratadine The metabolism of Cisapride can be decreased when combined with Loratadine.
Carvedilol Carvedilol The metabolism of Carvedilol can be decreased when combined with Cisapride.
Nilutamide Nilutamide The metabolism of Cisapride can be decreased when combined with Nilutamide.
Flutamide Flutamide The metabolism of Cisapride can be decreased when combined with Flutamide.
Selegiline Selegiline The metabolism of Cisapride can be decreased when combined with Selegiline.
Bicalutamide Bicalutamide The metabolism of Bicalutamide can be decreased when combined with Cisapride.
Sertraline Sertraline The metabolism of Cisapride can be decreased when combined with Sertraline.
Propafenone Propafenone The risk or severity of QTc prolongation can be increased when Propafenone is combined with Cisapride.
Letrozole Letrozole The metabolism of Cisapride can be decreased when combined with Letrozole.
Raloxifene Raloxifene The metabolism of Cisapride can be decreased when combined with Raloxifene.
Irbesartan Irbesartan The metabolism of Cisapride can be decreased when combined with Irbesartan.
Tamsulosin Tamsulosin The metabolism of Tamsulosin can be decreased when combined with Cisapride.
Ropinirole Ropinirole Cisapride may increase the sedative activities of Ropinirole.
Finasteride Finasteride The metabolism of Finasteride can be decreased when combined with Cisapride.
Quetiapine Quetiapine The risk or severity of QTc prolongation can be increased when Cisapride is combined with Quetiapine.
Cetirizine Cetirizine The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Cisapride.
Paroxetine Paroxetine The metabolism of Paroxetine can be decreased when combined with Cisapride.
Tolcapone Tolcapone The risk or severity of adverse effects can be increased when Tolcapone is combined with Cisapride.
Citalopram Citalopram The metabolism of Citalopram can be decreased when combined with Cisapride.
Capecitabine Capecitabine The metabolism of Capecitabine can be decreased when combined with Cisapride.
Efavirenz Efavirenz The risk or severity of QTc prolongation can be increased when Efavirenz is combined with Cisapride.
Sildenafil Sildenafil The metabolism of Cisapride can be decreased when combined with Sildenafil.
Pioglitazone Pioglitazone The metabolism of Cisapride can be decreased when combined with Pioglitazone.
Celecoxib Celecoxib The metabolism of Celecoxib can be decreased when combined with Cisapride.
Rosiglitazone Rosiglitazone The metabolism of Rosiglitazone can be decreased when combined with Cisapride.
Tolterodine Tolterodine The metabolism of Tolterodine can be decreased when combined with Cisapride.
Thalidomide Thalidomide Cisapride may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Nateglinide Nateglinide The metabolism of Nateglinide can be decreased when combined with Cisapride.
Galantamine Galantamine The metabolism of Cisapride can be decreased when combined with Galantamine.
Levetiracetam Levetiracetam The risk or severity of adverse effects can be increased when Levetiracetam is combined with Cisapride.
Rabeprazole Rabeprazole The metabolism of Cisapride can be decreased when combined with Rabeprazole.
Terbinafine Terbinafine The metabolism of Cisapride can be increased when combined with Terbinafine.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists

Still Confused? Ask the pharmacist a question here!